Neftaly’s Commitment to Reducing TB Mortality
Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, posing a significant public health challenge globally. According to the World Health Organization’s 2013 estimates, TB claimed millions of lives, underscoring the urgent need for coordinated action.
At Neftaly, we are dedicated to contributing towards the global goal of achieving a 25% reduction in TB mortality from the 2013 baseline. Through innovative solutions, community engagement, and strategic partnerships, Neftaly strives to:
- Enhance Early Detection and Diagnosis: Implementing advanced screening technologies and awareness campaigns to identify TB cases promptly.
- Improve Treatment Adherence: Providing support tools and education to ensure patients complete their full course of treatment, reducing drug resistance and relapse.
- Strengthen Healthcare Systems: Collaborating with healthcare providers to improve service delivery and access to quality care.
- Promote Research and Innovation: Supporting the development of new diagnostics, vaccines, and treatment protocols.
- Raise Awareness and Advocacy: Engaging communities and stakeholders to combat stigma and promote prevention strategies.


